This content is machine translated Apremilast Effective reduction of itching in the context of scalp psoriasis Visible pruritic lesions on the scalp are a major stress factor for many psoriasis patients. Topical preparations are used as first-line therapy, but these are not always effective, especially in…
View Post 3 min This content is machine translated Phase IIa study Tocilizumab for the treatment of Schnitzler syndrome Schnitzler syndrome is a rare autoinflammatory disorder. Core symptoms include chronic, recurrent hives. In particular, for patients who do not respond to anti-IL1 therapy, there is a need for new…
View Post 4 min This content is machine translated The somewhat different knowledge Who was actually… Moriz Kaposi? When Moriz Kaposi first described Kaposi’s sarcoma in 1872, he probably had no idea that this entity would become much more famous in the context of HIV/AIDS. He was much…
View Post 5 min This content is machine translated Psoriatic Arthritis New long-term data on guselkumab published Phase III data on the IL23p19 inhibitor guselkumab demonstrate complete resolution of skin symptoms and positive joint effects in adult patients with active psoriatic arthritis (PsoA) lasting over two years.
View Post 3 min This content is machine translated Studies in focus Interleukin-31 as a clinical target in prurigo nodularis. For the treatment of prurigo nodularis, there are rather few approved therapeutic options available today. There is a need for new effective and well-tolerated treatment options. The use of the…
View Post 6 min This content is machine translated Psoriasis as an inflammatory systemic disease Changing disease concept – implications for biologic therapy. Psoriasis is nowadays no longer understood as an exclusive skin disease, but rather as a systemic disease. Biologics specifically intervene in the disease process and have revolutionized treatment options. When…
View Post 1 min This content is machine translated Webinar Relevant aspects for the management of atopic dermatitis By way of introduction, the experts will present the principles of action of the new system therapies, the “disease burden” & comorbidities of atopic dermatitis. This will be followed by…
View Post 5 min This content is machine translated Scar treatment Laser medical applications for different types of scars – an update. The success of scar treatment depends on various factors. There is still no universally valid gold standard. An approach based on individual circumstances has proven successful. Depending on the type…
View Post 4 min This content is machine translated Atopic dermatitis Dupilumab newly approved in Switzerland from 12 years of age Especially in adolescents, moderate to severe atopic dermatitis is associated with a high degree of suffering. In the pivotal study, dupilumab resulted in rapid and sustained relief of skin lesions…
View Post 4 min This content is machine translated Psoriatic Arthritis Another JAK inhibitor has cleared the approval hurdle In patients with psoriatic arthritis who do not respond adequately to conventional DMARDs or a biologic, the EULAR recommendations advise the use of a JAK inhibitor. Recently, upadacitinib, another member…
View Post 10 min This content is machine translated Aesthetic dermatology Filler and thread lifting The natural aging process of the face leads to a loss of volume caused by the resorption of subcutaneous tissue. Over the years, not only the superficial and deep fat… CME-Test
